Phentermine-topiramate shows best chance of weight loss at 1 year
The combination weight-loss drug phentermine plus topiramate is associated with the highest odds of individuals being able to lose 5% of their body weight within 1 year, according to a meta-analysis... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 14, 2016 Category: Endocrinology Source Type: news
Adipex-P (Phentermine Hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 16, 2016 Category: Drugs & Pharmacology Source Type: news
Top-Selling Diet Drug Phentermine Is Cheap and Easy to Get
Phentermine, once part of the fen-phen drug combination taken off the market in the 1990s, is the best-selling diet pill today, often sold by doctors. (Source: NYT Health)
Source: NYT Health - July 4, 2015 Category: Consumer Health News Authors: KATIE THOMAS Tags: Drugs (Pharmaceuticals) Phentermine Food and Drug Administration Weight Diet and Nutrition Source Type: news
Phentermine for weight loss
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - February 25, 2015 Category: Consumer Health News Source Type: news
phentermine and topiramate extended-release (Qsymia)
Title: phentermine and topiramate extended-release (Qsymia)Category: MedicationsCreated: 2/23/2015 12:00:00 AMLast Editorial Review: 2/23/2015 12:00:00 AM (Source: MedicineNet Weight Management General)
Source: MedicineNet Weight Management General - February 23, 2015 Category: Eating Disorders and Weight Management Source Type: news
Lorcaserin and Phentermine Safe Combo in Weight-Loss TrialLorcaserin and Phentermine Safe Combo in Weight-Loss Trial
A new pilot study examines the effect of adding a new weight-loss drug, lorcaserin, to an old appetite suppressant, phentermine. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 11, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Obesity Drug Safety Debate Escalates in Medical Journal Obesity Drug Safety Debate Escalates in Medical Journal
Arguments and accusations fly as physicians and others debate the FDA's wisdom in approving lorcaserin and phentermine-topiramate. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 4, 2014 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
phentermine, Adipex-P, Fastin (Discontinued), Obenix, Oby-Trim (Discontinued), Suprenza
Title: phentermine, Adipex-P, Fastin (Discontinued), Obenix, Oby-Trim (Discontinued), SuprenzaCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/25/2014 12:00:00 AM (Source: MedicineNet Weight Management General)
Source: MedicineNet Weight Management General - July 25, 2014 Category: Eating Disorders and Weight Management Source Type: news
phentermine, Adipex-P, Fastin (Discontinued), Obenix, Oby-Trim (Discontinued), Suprenza
Title: phentermine, Adipex-P, Fastin (Discontinued), Obenix, Oby-Trim (Discontinued), SuprenzaCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/25/2014 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 25, 2014 Category: Drugs & Pharmacology Source Type: news
Is Belphen the Next Blockbuster Diet Drug?
(MedPage Today) -- Even though there are scant data, obesity researchers and patients have already put a name to a potential new weight-loss craze: Belphen, a combination of lorcaserin (Belviq) and phentermine. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 18, 2014 Category: Cardiology Source Type: news
New Obesity Drugs Provide 'Slim Pickings,' Say 2 ExpertsNew Obesity Drugs Provide 'Slim Pickings,' Say 2 Experts
There are still safety concerns with the 2 newest agents for obesity in the United States, lorcaserin and phentermine-topiramate, say 2 Dartmouth doctors. Medscape Medical News (Source: theHeart.org)
Source: theHeart.org - February 19, 2014 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news
Slim pickings for two weight-loss drugs?
Many medications for weight loss have been proposed or are under development. The Federal Drug Administration has approved few drugs for long-term weight loss, and some are no longer marketed because of safety issues, researchers of a new study have reported. In 2012, though, the FDA approved two drugs for long-term weight loss, lorcaserin hydrochloride (Belviq; Eisai Inc) and phentermine/topiramate (Qsymia; Vivus Inc). But Dartmouth researchers question how safe these two drugs are based on the FDA approval after one-year trials? (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 11, 2014 Category: Science Source Type: news
A safe, effective diet pill - the elusive holy grail
Trade in illegal, ineffective drugs flourishes as pharmaceutical industry repeatedly fails to produce successful pillAttempts to invent a safe and effective diet pill have foundered time and again, allowing the internet trade in illegal and ineffective herbal supplements and dangerous drugs, such as DNP, to flourish.A successful diet pill could make billions for the pharmaceutical industry, but efforts to date have ended in disaster, with patients harmed, drugs banned and massive compensation paid out.Fen-phen, an appetite suppressant, was the most spectacular failure. It was withdrawn in the US in 1997 after causing wides...
Source: Guardian Unlimited Science - January 14, 2014 Category: Science Authors: Sarah Boseley Tags: The Guardian Diets and dieting Drugs trade Healthcare industry World news Pharmaceuticals industry & wellbeing Health policy Society Politics UK news Life and style Public services policy Business Science Source Type: news
Qsymia Trims Sleep Apnea as Well as Weight (CME/CE)
ATLANTA (MedPage Today) -- Obese patients treated with the weight-loss combination of phentermine plus topiramate (Qsymia ER) for 28 weeks lost significant amounts of weight and also saw relief from their obstructive sleep apnea, researchers found. (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 15, 2013 Category: Endocrinology Source Type: news
Combo Drug Qsymia Tops for Weight Loss
(MedPage Today) -- Overweight people who took the phentermine/topiramate combination diet drug Qsymia lost more weight than people taking a placebo or either drug alone in an industry-funded study. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - October 29, 2013 Category: Pediatrics Source Type: news
